Primary Category:
Treatment Protocols
Disease Category:
Endometrial, Endometrial Metastatic, GYN Other, Gynecologic, Ovarian, Ovarian Metastatic
Status:
Open
A Randomized Trial of Selumetinib and Olaparib or Selumetinib Alone in Patients with Recurrent or Persistent RAS Pathway Mutant Ovarian and Endometrial Cancers: A ComboMATCH Treatment Trial
NCT#05554328
(See required screening study ECOG-ACRIN EAY191)
